Reply to “Innovation and off‐label use, the French case and more” by Braillon and Lexchin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reply to “Innovation and off‐label use, the French case and more” by Braillon and Lexchin

Published:2019-08-13 Issue:10 Volume:85 Page:2448-2449
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Borysowski Jan¹²^ORCID,Ehni Hans‐Jörg³,Górski Andrzej²⁴

Affiliation:

1. Centre for Studies on Research Integrity, Institute of Law StudiesPolish Academy of Sciences Warsaw Poland

2. Department of Clinical ImmunologyMedical University of Warsaw Warsaw Poland

3. Institute of Ethics and History of MedicineEberhard Karls Universität Tübingen Germany

4. Laboratory of Bacteriophages, Ludwik Hirszfeld Institute of Immunology and Experimental TherapyPolish Academy of Sciences Wrocław Poland

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14068

Reference9 articles.

1. Innovation and off‐label use, the French case and more

2. Ethics codes and use of new and innovative drugs

3. Association of Off-label Drug Use and Adverse Drug Events in an Adult Population

4. Off-label treatments were not consistently better or worse than approved drug treatments in randomized trials

5. Off-Label Use of Approved Drugs: Therapeutic Opportunity and Challenges

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP